MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Protein Degradation and Inhibitors
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

818 results · 1 filter active ·
Results by year
20022025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
818 works in the cohort · of 4,299,418page 13 of 17

Labels cover 1 of 818 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 818 of 818 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

fundno affunlabeled
Genetic Pharmacotherapy
Rehan Haider
2023· article· en· International Journal of Scientific Multidisciplinary Research· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Abstract 626: Apabetalone (Rvx-208), a Selective Bet Protein Inhibitor, Reduces Expression of Acute Phase Response Markers <i>in vitro</i> and in Patients With Cardiovascular Disease and Chronic Kidney Disease
Ewelina Kulikowski, Sylwia Wasiak, Dean Gilham, Laura Tsujikawa, Christopher Halliday, Ravi Jahagirdar +2 more
2017· article· en· Arteriosclerosis Thrombosis and Vascular Biology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
ABCL-412 Clinical Activity of CC-99282, a Novel, Oral, Small Molecule Cereblon E3 Ligase Modulator (CELMoD) Agent, in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) –Results From CC-99282-NHL-001 (NCT03930953) a First-in-Human, Phase 1, Open-Label, Multicenter Study
Julio C. Chávez, Jean‐Marie Michot, Cecilia Carpio, Silvia Martina Ferrari, Tatyana Feldman, Daniel Morillo +13 more
2022· article· en· Clinical Lymphoma Myeloma & Leukemia· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
2022 Brina C. Kessel Award to Benjamin M. Winger and Teresa M. Pegan
Michael T. Murphy, Nathan W. Cooper, Kevin C. Fraser, Elizabeth A. MacDougall‐Shackleton, Sara J. Oyler‐McCance, Henry M. Streby
2022· article· en· The Auk· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · insufficient_payloadconsensus · none
0
citations
venueno affunlabeled
crave
Millie Chen
2002· article· en· Tessera· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About